Results 361 to 370 of about 524,198 (385)

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Leticia M Nogueira   +2 more
exaly  

Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.

European journal of internal medicine, 2021
HK Björnsson, ES Björnsson
semanticscholar   +1 more source

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

Ca-A Cancer Journal for Clinicians, 2023
Demetrios Moris
exaly  

Case Definition and Phenotype Standardization in Drug‐Induced Liver Injury

Clinical pharmacology and therapy, 2011
G. Aithal, P. Watkins, R. Andrade, D. Larrey, M. Molokhia, H. Takikawa, C. Hunt, R. Wilke, M. Avigan, N. Kaplowitz, Einar Björnsson, A. Daly   +11 more
semanticscholar   +1 more source

The gut–liver axis and gut microbiota in health and liver disease

Nature Reviews Microbiology, 2023
Cynthia Li-Shin Hsu, Bernd Schnabl
exaly  

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Ca-A Cancer Journal for Clinicians, 2018
Frank Bray, Jacques Ferlay, Isabelle Soerjomataram   +2 more
exaly  

Cancer statistics in China, 2015

Ca-A Cancer Journal for Clinicians, 2016
Rongshou Zheng, Peter D Baade, Siwei Zhang   +2 more
exaly  

Drug-Induced Liver Injury Network

The American Journal of Gastroenterology, 2008
openaire   +2 more sources

Global Cancer Statistics, 2002

Ca-A Cancer Journal for Clinicians, 2005
Frank Bray
exaly  

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

Ca-A Cancer Journal for Clinicians, 2017
Farhad Islami, Rebecca L Siegel, Elizabeth M Ward   +2 more
exaly